SKIP TO CONTENT
  • Home
  • About
    • Careers
  • People
  • Practice Areas
    • Patents
    • Trademarks & Brand Protection
    • Copyright
    • IP Strategy
    • IP Transactions
    • Corporate & Business Transactions
    • M&A Advisory
    • VC Due Diligence
  • Industries
  • Newsroom
  • Contact
Make A Payment
Visit us on Visit us on Visit us on
  • Industries
  • Aerospace
  • Artificial Intelligence
  • Biotechnology & Pharmaceuticals
  • Biomedical Devices
  • Financial Services
  • Electronics & Semiconductors
  • Energy & Sustainability
  • Engineering & Robotics
  • Industrial Chemistry
  • Materials Science
Johnson, Marcou, Isaacs & Nix, LLC logo Johnson, Marcou, Isaacs & Nix, LLC logo
Visit us on Visit us on Visit us on
Make A Payment

newsroom

Apr 27 2026

Teva v. Lilly: The “Well-Known Genus Used as Part of a Different Invention” Doctrine Gets a Federal Circuit Revival

By: Brent Nix
By: Brent Nix
April 27, 2026
Insights
On April 16, 2026, the Federal Circuit reversed a District of Massachusetts JMOL that had erased a $176.5 million jury […]...
Insights
Read More
Oct 27 2025

USPTO Streamlined Claim Set Pilot Program

By: Brent Nix
By: Brent Nix
October 27, 2025
Insights
The USPTO launched a new Streamlined Claim Set Pilot Program on October 27, 2025, offering expedited examination for certain utility...
Insights
Read More
Oct 8 2025

USPTO Update – Automated Search Pilot Program

By: Brent Nix
By: Brent Nix
October 8, 2025
General
The USPTO takes another step in the direction of AI-assisted search with a new pilot program. Starting October 20, the […]...
General
Read More
Sep 29 2025

UniCure Reports Positive 3-Year Huntington’s Gene Therapy Data: Unique IP Considerations for Complex Gene Therapy Programs

By: Brent Nix
By: Brent Nix
September 29, 2025
Insights
UniCure announced positive 3-year data for their Huntington’s disease gene therapy this week, with the company receiving FDA...
Insights
Read More
May 16 2025

Willful Enough: How Halozyme Is Putting Merck on Notice

By: Erin Daly
By: Erin Daly
May 16, 2025
General
In the ongoing litigation between Halozyme, Inc. and Merck Sharp & Dohme Corp., the issue of willful patent infringement takes...
General
Read More
Page 1 of 612345...NextLast

Categories

  • Firm News
  • General
  • Insights
  • News
  • Patents
  • Procedure

Articles by Attorneys

Articles by Practices

Archives

Related Posts

  • USPTO Streamlined Claim Set Pilot Program
  • UniCure Reports Positive 3-Year Huntington’s Gene Therapy Data: Unique IP Considerations for Complex Gene Therapy Programs
  • Willful Enough: How Halozyme Is Putting Merck on Notice
  • Patent Eligibility of Diagnostic Gene Signature Method Claims

subscribe

Subscribe to our newsletter

Contact Us

P: 912-257-4864

E: info@jmin.com

Johnson, Marcou, Isaacs & Nix, LLC

27 City Square, Suite 1
P.O. Box 691

Hoschton, GA 30548

Visit our social media at: https://www.facebook.com/JMINiplaw/ Visit our social media at: https://twitter.com/jmin_iplaw Visit our social media at: https://www.linkedin.com/company/johnson-marcou-isaacs-nix-llc/
MAKE A PAYMENT
© 2026 Johnson, Marcou, Isaacs & Nix, LLC. All Rights Reserved. Sitemap Disclaimer Privacy Policy A PaperStreet Web Design
connect